Ultragenyx (RARE) came out with a quarterly loss of $1.81 per share versus the Zacks Consensus Estimate of a loss of$1.23. This compares to a loss of $1.4 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -47.15$1.27 per share when it actually produced a loss of $1.17, delivering a surprise of +7.87%.Over the last four quarters, the company h ...